Showing results (101-110 of 363) with videos related to
Sort By:
Pageof 37
Heart (British Cardiac Society)|May 3, 2005
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart diseaseS D Robinson, C A Ludlam, N A Boon, et al.Scottish Medical Journal|August 1, 1993
Dilated cardiomyopathy in haemophiliacs infected with the human immunodeficiency virusA J Jacob, G R Sutherland, N A Boon, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2005
Management of acquired von Willebrand's syndrome in a patient requiring major surgeryJ M Maddox, J A M Anderson, D Plews, et al.British Journal of Haematology|June 1, 1979
An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serumI R Peake, A L Bloom, J C Giddings, et al.Journal of Thrombosis and Haemostasis : JTH|July 14, 2006
Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart diseaseS D Robinson, C A Ludlam, N A Boon, et al.Circulation|June 15, 1999
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failureN E Goodfield, D E Newby, C A Ludlam, et al.British Journal of Cancer|September 1, 1984
Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assayA P Simmonds, E C McDonaldReviews of Environmental Contamination and Toxicology|January 1, 1994
Organochlorine contamination in pinnipedsJ D Hutchinson, M P SimmondsAustralian and New Zealand Journal of Medicine|June 1, 1993
Thymic hyperplasia in adults following chemotherapy for malignancyP Simmonds, M Silberstein, J McKendrickPageof 37